Morgan, T M
Hawken, S R
Ghani, K R
Miller, D C
Feng, F Y
Linsell, S M
Salisz, J A
Gao, Y
Montie, J E
Cher, M L
,
Article History
Received: 24 November 2015
Revised: 29 December 2015
Accepted: 26 January 2016
First Online: 8 March 2016
Competing interests
: TMM is a consultant/advisor for and receives research funding from Myriad Genetics. KRG is a consultant/advisor for Lumenis and Boston Scientific, and receives salary support from Blue Cross Blue Shield of Michigan as the co-director of the Michigan Urological Surgery Improvement Collaborative. DCM receives salary support from Blue Cross Blue Shield of Michigan as the director of the Michigan Urological Surgery Improvement Collaborative and the Michigan Value Collaborative. FYF has a leadership role at PFS Genomics, is a consultant/advisor for Medivation/Astellas, GenomeDx Biosciences and Celgene, and has research funding from Varian, Celgene and Medivation/Astellas. JEM is a consultant/advisor for and has ownership in Histosonics. MLC was part of Astellas-Medivation speaker’s bureau. The remaining authors declare no conflict of interest.